Official Publications argenx SE

Equities

Real-time Euronext Bruxelles Other stock markets 01:18:20 30/04/2024 pm IST			5-day change	1st Jan Change
349.1 ^EUR	+0.17%		+0.14%	+1.80%

17/04	European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	MT
16/04	Argenx SE Announces Data from its Phase 3 ADHERE Trial Evaluating VYVGART Hytrulo in Patients with Chronic Inflammatory Demyelinating Polyneuropathy	CI

Mixed general shareholder meeting	26/03	CO
SEC Filing 20 F	21/03	CO
Annual ESG Report	21/03	CO
Annual Report	21/03	CO
SEC Filing 13G	29/02	CO
SEC Filing 6K-4	29/02	CO
Slide show results	29/02	CO
Annual results	29/02	CO
Threshold crossings	01/02	CO
Threshold crossings	31/01	CO
Threshold crossings	26/01	CO
Admission of new securities	31/12	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	19/12	CO
Threshold crossings	01/11	CO
Slide show Q3	31/23/31	CO
3rd quarter results	31/23/31	CO
SEC Filing 6K-3	31/23/31	CO
Threshold crossings	20/23/20	CO
Admission of new securities	30/23/30	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	20/23/20	CO
Threshold crossings	19/23/19	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	15/23/15	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	12/23/12	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	08/23/08	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	31/23/31	CO